Deletion of the transcription factor ATF4 in a model of clear cell renal cell carcinoma
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Division of Cancer Prevention, National Cancer Institute (5T32CA062948)
- Weill Cornell Medicine
- National Institutes of Health
- Medical College, Weill Cornell Medicine
- U.S. Department of War (W81XWH-22-1-0873)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK113088)
This publication has 50 references indexed in Scilit:
- Renal Cell CarcinomaJAMA, 2024
- Transcriptome- and proteome-wide association studies identify genes associated with renal cell carcinomaThe American Journal of Human Genetics, 2024
- Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR)Molecular Carcinogenesis, 2022
- Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis BlockadeCancer Cell, 2020
- Integrated Proteogenomic Characterization of Clear Cell Renal Cell CarcinomaCell, 2019
- Study of FABP's interactome and detecting new molecular targets in clear cell renal cell carcinomaJournal of Cellular Physiology, 2019
- The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell CarcinomaCell Reports, 2017
- The role of HIF1α in renal cell carcinoma tumorigenesisJournal of Molecular Medicine, 2014
- HIF and c-Myc: Sibling Rivals for Control of Cancer Cell Metabolism and ProliferationCancer Cell, 2007
- The life cycle of neutral lipids: synthesis, storage and degradationCellular and Molecular Life Sciences, 2006